|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for antineoplastic chemotherapy and immunotherapy
ICD-10 (CM) Code and Descriptor
Z51.11 |
Encounter for antineoplastic chemotherapy
|
Z5111 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
74.26%
|
11.69%
|
5.62%
|
2.94%
|
1.74%
|
1.06%
|
0.71%
|
0.48%
|
0.35%
|
0.28%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z51.11*:
CPT |
Description |
Number of Claims |
Sum Performed |
96413
|
CHEMO IV INFUSION 1 HR |
911,122
|
911,229
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
799,289
|
799,555
|
80053
|
COMPREHEN METABOLIC PANEL |
730,762
|
730,838
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
603,610
|
1,141,521
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
477,732
|
6,244,436
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
429,031
|
519,180
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
374,165
|
375,085
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
360,732
|
362,758
|
96367
|
TX/PROPH/DG ADDL SEQ IV INF |
337,083
|
448,064
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
319,769
|
14,402,837
|
96417
|
CHEMO IV INFUS EACH ADDL SEQ |
295,921
|
338,464
|
J2469
|
PALONOSETRON HCL |
246,890
|
2,482,496
|
J2405
|
ONDANSETRON HCL INJECTION |
228,869
|
2,649,657
|
96415
|
CHEMO IV INFUSION ADDL HR |
225,299
|
343,585
|
83735
|
ASSAY OF MAGNESIUM |
217,756
|
218,104
|
J1200
|
DIPHENHYDRAMINE HCL INJECTIO |
206,539
|
214,559
|
J9190
|
FLUOROURACIL INJECTION |
188,798
|
1,154,463
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
165,186
|
165,900
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
162,867
|
183,430
|
J7040
|
NORMAL SALINE SOLUTION INFUS |
155,695
|
173,984
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z51.11 related to the following DRG Codes:
826-828 829-830 837-839 846-848
|